Work

So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients

Year: 2015

Type: editorial

Source: Circulation Cardiovascular Genetics

DOI: 10.1161/circgenetics.115.001256

Authors: Markey C. McNutt, Zahid Ahmad

Institution: The University of Texas Southwestern Medical Center

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Sanofi, Regeneron Pharmaceuticals, U.S. Food and Drug Administration

OpenAlex ID: W2213977181

Cites: 10

Cited by: 1

Related to: 10